STRUCTURAL TRANSFORMATIONS IN AXILLARY AND MESENTERIC LYMPH NODES IN CHEMOTHERAPY AND SURGICAL TREATMENT OF EXPERIMENTAL MAMMARY TUMOR

Author: Kazakov O.V.¹, Kabakov A.V.², Poveshchenko A.F.³, Rayter T.V.⁴, Strunkin D.N.⁵, Lykov A.P.⁶, Konenkov V.I.⁷

Abstract

Was conducted histological study axillary and mesenteric lymph nodes in breast cancer induced by intramammary administration of N-methyl-N-nitrosourea, chemotherapy according to the CMF scheme (cyclophosphamide, methotrexate, 5-fluorouracil), operative removal of breast tumors (6.5 months from the beginning of the experiment). The results of the study. At chemotherapy of breast cancer, compared with the group with breast cancer without treatment, there was a decrease in the number of tumor cells in the axillary lymph nodes in comparison with mesenteric lymph nodes. The decrease in the area of the paracortical zone and the area of secondary lymphoid nodes remain in the axillary lymph nodes, in comparison with breast cancer without treatment. The reduction of the paracortical zone square remains in mesenteric lymph nodes. The area of lymphoid nodules with germinative centers decreases. The number of postcapillary venules with high endothelium and the number of macrophages in structural zones grow down. In the axillary lymph nodes after surgical treatment of breast cancer and chemotherapy in comparison with the treatment of breast cancer only with cytostatics, there is decrease in the area of the paracortical zone (with an increase in the number of small lymphocytes) and medullare cords. The area of lymphoid nodules with germinative and without germinative centers increases. In mesenteric lymph nodes, drainage function is reduced, increased the area of the paracortical zone, reduced the areas of lymphoid nodules with germinative centers and medullare cords (increased proliferative activity of cells), macrophage reaction in the cortical substance was revealed. Conclusion. The severity of structural transformations in cytoarchitectonics of the axillary and mesenteric lymph nodes depends on the treatment method.

Key words

mammary gland, lymph nodes, tumor, surgical treatment, preventive treatment

References

1. Volkova M.S., Astashov V.V., Kazakov O.V., Larionov P.M., Chepik V.I. Study of lymph nodes in experimental mammary tumor. Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Biologiya, klinicheskaya meditsina = Journal of the Novosibirsk State University. Series: Biology, clinical medicine. 2011; 9 (1): 152-158. [In Russian].

2. Kabakov A. V., Lykov A. P., Morozov D. V., Kazakov O. V., Poveshchenko A. F., Rajter T. V., Strunkin D. N., Konenkov V. I. Phenotypical characteristics of chemically induced mammary tumor. Bull. Exp. Biol. Med. 2017; 163 (4): 490-492. doi: 10.1007/s10517-017-3835-6

3. Kazakov O.V., Kabakov A.V., Poveshhenko A.F., Miller T.V., Chepik V.I., Rajter T.V., Strunkin D.N., Larionov P.M., Konenkov V.I. Thymus in experimental carcinogenesis of the mammary gland. Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Biologiya, klinicheskaya meditsina = Journal of the Novosibirsk State University. Series: Biology, clinical medicine. 2014; 12 (3): 58-62. [In Russian].

4. Kazakov O.V., Kabakov A.V., Ishhenko I.Ju., Poveshhenko A.F., Rajter T.V., Strunkin D.N., Michurina S.V., Konenkov V.I. The thymus in experimental mammary carcinogenesis and polychemotherapy. Bull. Exp. Biol. Med. 2017; 162 (4): 479–482. doi: 10.1007/s10517-017-3644-y

5. Kazakov O.V., Kabakov A.V., Ishhenko I.Ju., Poveshhenko A.F., Rajter T.V., Strunkin D.N., Raiter T.V., Michurina S.V., Konenkov V.I. Changes in the structure of the thymus under conditions of various treatments for experimental mammary tumor. Bull. Exp. Biol. Med. 2017; 162 (5): 654-657. doi: 10.1007/s10517-017-3680-7

6. Majborodin I.V., Strunkin D.N., Majborodina V.I., Kulikova O.V., Lebedev A.A., Zarubenkov O.A., Cherenkova M.M. Changes in group lymphoid nodules and mesenteric lymph nodes of rats after the introduction of a complex of chemotherapeutic drugs: similarity and differences in response. Morfologiya = Morphology. 2007; 132 (5): 68-73. [in Russian].

7. Poveshhenko A.F., Kazakov O.V., Orlov N.B., Poveshhenko O.V., Kim I.I., Bondarenko N.A., Solovyova I.G., Strunkin D.N., Kabakov A.V., Reiter T.V., Lykov A.P., Bogachev S.S., Pokushalov E.A., Konenkov V.I. Cytokines of lymph as markers of cancer progression and effectiveness of therapy in experimental breast tumors of rats WISTAR. Patologicheskaya fiziologiya i eksperimental'naya terapiya = Pathological physiology and experimental therapy. 2016; 60 (3): 68-75. [In Russian].

8. Fil'chenkov A.A. Lymphangiogenesis and metastasis of tumors. Onkologiya = Oncology. 2009; 11 (2): 94-103. [In Russian].

9. Allred C.D., Allred K.F., Ju Y.H, Clausen L.M., Doerge D.R., Schantz S.L., Korol D.L., Wallig M.A., Helferich W.G. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis. 2004; 25 (2): 211-218. doi: 10.1093/carcin/bgg198.

10. Esendagli G., Yilmaz G., Canpinar H., Gunel-Ozcan А., Guc M., Guc D. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats. Lab. Animals. 2009; 43 (1): 60-64. doi: 10.1258/la.2008.007076

11. Farnsworth R.H., Karnezis T., Shayan R., Matsumoto M., Nowell C.J., Achen M.G., Stacker S.A. Vascular remodeling in cancer. Oncogene. 2014; 33 (27): 3496-3505. doi:10.1038/onc.2013.304

12. Ikezawa Y., Nakazawa M., Tamura C., Takahashi K., Minami M., Ikezawa Z. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. J. Dermatol. Sci. 2005; 39 (2):105-112. doi: 10.1016/j.jdermsci.2005.02.002

13. Lopez D.M., Charyulu V., Adkins B. Influence of breast cancer on thymic function in mice. Mammary Gland Biol. Neoplasia. 2002; 7(2):191-199. doi: 10.1023/A:1020356020542

14. Mailloux A.W., Young M.R. Regulatory T-cell trafficking: from thymic development to tumorinduced immune suppression. Crit. Rev. Immunol. 2010; 30 (5): 435-447.

15. Meneses A., Verastegui E., Barrera J.L., de la Garza J., Hadden J.W. Lymph node histology in head and neck cancer: Impact of immunotherapy with IRX-2. Int. Immunol. 2003; 3 (8): 1083-1091. doi: 10.1016/S1567-5769(03)00017-1

16. Su Y.C., Rolph M.S., Cooley M.A., Sewell W.A. Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. J. Allergy Clin. Immunol. 2006; 117 (3): 635-641. doi: 10.1016/j.jaci.2005.10.042

17. Tsubura A., Lai Y.C., Miki H., Sasaki T., Uehara N., Yuri T., Yoshizawa K. Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials. In Vivo. 2011; 25 (1): 11-22.

About Authors (Correspondence):

Kazakov O.V., e-mail: kazakoff_oleg@mail.ru

Full Text

snmzh_5-2019_kazakov_i_dr.pdf

Received: 30/10/2019

Accepted: 30/10/2019